Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up Women only

Intrathecal versus epidural morphine for pain after cesarean delivery

Official title: Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia: A Randomized Controlled Trial

Run by Hospital Central do Funchal · NCT07386353 · Data updated 2026-11-12

This test will compare a single intrathecal morphine shot versus epidural morphine for controlling pain in women having elective cesarean delivery.

More Analgesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment120 (estimated)
SponsorHospital Central do Funchal
Academic / other
Locations1 site (Funchal, Madeira)
StatusRecruiting
StartedMay 20, 2024
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedFebruary 4, 2026
Trial IDNCT07386353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women over 18 scheduled for elective cesarean who can receive neuraxial anesthesia and provide informed consent.

Probably not a fit

Patients with opioid tolerance, contraindications to neuraxial anesthesia, significant renal impairment (GFR <60 mL/min), or ASA physical status >III are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This unicentric randomized clinical trial will enroll pregnant women undergoing elective cesarean delivery at Hospital Central do Funchal. Participants will be randomly assigned to receive either 80 mcg intrathecal morphine at the end of surgery or epidural morphine given as a 2.5 mg bolus at the end of surgery with a second 2.5 mg bolus 24 hours later. The primary outcome is pain intensity during the first 24 postoperative hours, and secondary outcomes include pain at 48 hours, need for rescue analgesia, sedation, nausea/vomiting, pruritus, impact on mobilization and maternal satisfaction. Outcomes will be collected during the immediate postoperative period and up to 48 hours to compare analgesic effectiveness and side-effect profiles.

Why it matters

Potential benefit: If intrathecal morphine proves superior, patients could have better early post-cesarean pain control, reduced need for additional opioids, and easier newborn care.

How similar studies have gone: Previous studies are mixed—older trials favored epidural morphine while more recent evidence suggests intrathecal morphine may provide superior analgesia, but the data are limited and inconclusive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women scheduled for elective cesarean section;
* Age \> 18 years;
* Willingness to participate in the study, as demonstrated by signed informed consent.

Exclusion Criteria:

* American Society of Anesthesiologists (ASA) physical status classification \> III;
* Chronic kidney disease with a glomerular filtration rate \< 60 mL/min;
* Relevant drug allergies (particularly to protocol medications);
* Opioid tolerance;
* Contraindication to neuraxial anesthetic techniques.

Where it's running

  • Hospital Central do Funchal
    Funchal, Madeira, Portugal
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.